Journal article icon

Journal article

Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol

Abstract:

As of September 30, 2015, a total of 1589 laboratory-confirmed cases of infection with the Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported to the World Health Organization (WHO). At present there is no effective specific therapy against MERS-CoV. The use of convalescent plasma (CP) has been suggested as a potential therapy based on existing evidence from other viral infections. We aim to study the feasibility of CP therapy as well as its safety and clinical and labo...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1186/s40064-015-1490-9

Authors


Hajeer, AH More by this author
Bouchama, A More by this author
Hayden, FG More by this author
Expand authors...
Wellcome Trust More from this funder
World Health Organization More from this funder
Publisher:
SpringerPlus Publisher's website
Journal:
SpringerPlus Journal website
Volume:
4
Issue:
709
Publication date:
2015-10-19
Acceptance date:
2015-10-29
DOI:
ISSN:
2193-1801
Pubs id:
pubs:579327
URN:
uri:e662c4fd-edb1-4dbf-9d5e-94328d9e917e
UUID:
uuid:e662c4fd-edb1-4dbf-9d5e-94328d9e917e
Local pid:
pubs:579327
Paper number:
709

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP